108 related articles for article (PubMed ID: 2795432)
1. Uptake of CD-349 and nitrendipine into bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
J Pharmacobiodyn; 1989 Apr; 12(4):228-34. PubMed ID: 2795432
[TBL] [Abstract][Full Text] [Related]
2. Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
Biochem Pharmacol; 1989 Jun; 38(12):1985-91. PubMed ID: 2545208
[TBL] [Abstract][Full Text] [Related]
3. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
Jpn J Pharmacol; 1991 Nov; 57(3):337-48. PubMed ID: 1667534
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
5. Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.
Rogart RB; deBruyn Kops A; Dzau VJ
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7452-6. PubMed ID: 2429306
[TBL] [Abstract][Full Text] [Related]
6. Effect of S-312, a new calcium channel blocker, on the 1,4-dihydropyridine binding sites in porcine basilar blood vessels and rat aortic smooth muscle cells.
Mihara S; Fujimoto M
Jpn J Pharmacol; 1991 Jul; 56(3):249-59. PubMed ID: 1832726
[TBL] [Abstract][Full Text] [Related]
7. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
Pang DC; Sperelakis N
Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
[TBL] [Abstract][Full Text] [Related]
8. Isolation from rat brain tissue of an inhibiting activity for dihydropyridine binding sites and voltage-dependent CA2+ uptake.
Sanna E; Hanbauer I
Neuropharmacology; 1987 Dec; 26(12):1811-4. PubMed ID: 2830557
[TBL] [Abstract][Full Text] [Related]
9. [3H]-nitrendipine binding in normal and cardiomyopathic hamster hearts: modulation by temperature, verapamil and diltiazem.
Howlett SE; Gordon T
J Mol Cell Cardiol; 1990 Sep; 22(9):975-85. PubMed ID: 2177794
[TBL] [Abstract][Full Text] [Related]
10. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
11. Allosteric interaction of trimebutine maleate with dihydropyridine binding sites.
Nagasaki M; Kurosawa H; Naito K; Tamaki H
Eur J Pharmacol; 1990 Jul; 189(1):71-6. PubMed ID: 2171963
[TBL] [Abstract][Full Text] [Related]
12. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
Murphy BJ; Washkurak AW; Tuana BS
Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation.
Kawamoto JH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Cardiovasc Pharmacol; 1990 May; 15(5):714-9. PubMed ID: 1692930
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blocking and vasodilating actions of the novel dihydropyridine derivative AE0047.
Nishikawa M; Gohda M; Shinyama H; Matzno S; Yamanaga K; Kido H; Nakamura N
Clin Exp Pharmacol Physiol; 1998 May; 25(5):347-54. PubMed ID: 9612662
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of adrenoceptors and [3H]nitrendipine receptors of porcine vascular smooth muscle: differences between coronary artery and aorta.
Nishimura J; Kanaide H; Nakamura M
Circ Res; 1987 Jun; 60(6):837-44. PubMed ID: 3036396
[TBL] [Abstract][Full Text] [Related]
16. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
[TBL] [Abstract][Full Text] [Related]
17. Characterization of calcium channel antagonist binding sites labeled by [3H]nitrendipine in porcine coronary artery and aorta.
Yamada S; Harada Y; Nakayama K
Eur J Pharmacol; 1988 Sep; 154(2):203-8. PubMed ID: 2852598
[TBL] [Abstract][Full Text] [Related]
18. Nitrendipine potentiates Bay k 8644-induced contraction of isolated porcine coronary artery: evidence for functionally distinct dihydropyridine receptor subtypes.
Dube GP; Baik YH; Vaghy PL; Schwartz A
Biochem Biophys Res Commun; 1985 May; 128(3):1295-302. PubMed ID: 2408616
[TBL] [Abstract][Full Text] [Related]
19. Interaction between propranolol and calcium channel blockers in cardiac and vascular smooth muscle.
Weishaar RE; Quade MM; Pugsley TA; Shih YH; Taylor DG
J Mol Cell Cardiol; 1988 Oct; 20(10):897-903. PubMed ID: 3216400
[TBL] [Abstract][Full Text] [Related]
20. Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes.
Sarmiento JG; Janis RA; Katz AM; Triggle DJ
Biochem Pharmacol; 1984 Oct; 33(20):3119-23. PubMed ID: 6487362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
